Literature DB >> 23720106

A model of complaint based for overcrowding emergency department: Five-Level Hacettepe Emergency Triage System.

Doğaç Niyazi Ozüçelik1, Mehmet Mahir Kunt, Mehmet Ali Karaca, Bülent Erbil, Bülent Sivri, Ahmet Sahin, Yeşim Cetinkaya Şardan, Mehmet Mahir Ozmen, Bahar Güçiz Doğan.   

Abstract

BACKGROUND: To compare ESI Five-Level Triage System with 5-Level Hacettepe Emergency Triage System (HETS), which was developed for Overcrowded EDs in our country.
METHODS: Over a period of six days, patients were assessed by a different ED staff everyday using HETS, then re-evaluated blindly by an emergency physician using HETS. Then patients were evaluated blindly for a third time by an independent, ESI-using emergency physician.
RESULTS: Of the patients in the study, 133 were men, 175 were women and the average age was 44.41±18.033. Inter-rater agreement was 97.40% (Kappa=0.963) between HETS and HETS-Blind, 74.35% (Kappa=0.646) between HETS and ESI-Blind, 74.67% (Kappa=0.652) between HETS-Blind and ESI-Blind. Inter-observer agreement between the second emergency physician performing HETS-Blind and the first emergency physician, resident, or nurse was very good (Kappa=1.0). Intern doctor, non-medical secretary and paramedic were found to have almost very good agreement (Kappa=0.971; 0.935; 0.864, respectively). An overtriage of 7.25% and undertriage of 1.08% were found in HETS.
CONCLUSION: Complaint-based HEST developed for overcrowded Eds is a triage system with a very good agreement between observations and observers. Low undertriage and overtriage ratios, and easy application by all staff from a non-medical secretary to the emergency physician.

Entities:  

Mesh:

Year:  2013        PMID: 23720106     DOI: 10.5505/tjtes.2013.44789

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  1 in total

1.  Investigation on legal problems encountered by emergency medicine physicians in Turkey.

Authors:  Afsin Emre Kayipmaz; Cemil Kavalci; Betul Gulalp; Ummu Gulsum Kocalar; Tufan Akin Giray; Hasan Yesilagac; Betul Akbuga Ozel; Elif Celikel; Ozlem Karagun
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.